← Back to Clinical Trials
Recruiting NCT02425540
NCT02425540 Characterization of Ovarian Masses Unable to Classify With Gynecological Ultrasonography: Value of Pelvic MRI With Perfusion- and Diffusion-weighted Imaging
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT02425540 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Undetermined Ovarian Mass |
| Study Type | OBSERVATIONAL |
| Enrollment | 74 participants |
| Start Date | 2015-03 |
| Primary Completion | 2025-02 |
Trial Parameters
Condition Undetermined Ovarian Mass
Sponsor Universitaire Ziekenhuizen KU Leuven
Study Type OBSERVATIONAL
Phase N/A
Enrollment 74
Sex FEMALE
Min Age N/A
Max Age N/A
Start Date 2015-03
Completion 2025-02
Interventions
Pelvic MRI
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The aim of the study is to prospectively evaluate the value of pelvic MRI including diffusion- and perfusion-weighted sequences in the selected group of patients that have an undetermined ovarian mass at ultrasound.
Eligibility Criteria
Inclusion Criteria: \*Any woman with an adnexal mass undetermined by gynecological ultrasound Exclusion Criteria: * Any lesion with definite diagnosis by gynecological ultrasound * Denial or withdrawal of oral informed consent. * Contra-indication for MRI
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology